SETD2 and nonpapillary renal cell carcinoma: To further test this view, we inspected the DDR in ccRCC cell lines containing inactivating mutations in SETD2 that result in a strong reduction of H3K36me3 levels (Figure 6A) (Duns et al., 2010).